Jerry McMahon discusses Harpoon's novel antibody-derived platform which has been designed to use t-cells to target and destroy solid tumors in prostate, ovarian, pancreatic and other solid cancers.
Arix Bioscience is a healthcare and life science company that drives value in private and public companies through operational and strategic support and direction as well as patient capital.
Industry: Financial Services
Contact: +44 (0)20 7290 1050
20 Berkeley Square, London, W1J 6EQ, United Kingdom